REQUEST A DEMO
Total
USD $0.00
Search more companies

Biominerales Pharma S A S (Colombia)

Main Activities: All Other Crop Farming
Full name: Biominerales Pharma S A S Profile Updated: July 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Biominerales Pharma S A S is a company based in Colombia, with its head office in Bogota D.C.. It operates in the All Other Crop Farming industry. The enterprise was incorporated on February 28, 2017. It currently has a total number of 3 (2024) employees. From the latest financial highlights, Biominerales Pharma S A S reported a net sales revenue increase of 133.24% in 2023. A negative growth of 32.67% was recorded in its total assets. The net profit margin of Biominerales Pharma S A S increased by 1635.96% in 2023.

Headquarters
Ac. 17 # 132 18 Int. 2
Bogota D.C.; Bogota D.C; Postal Code: 0704

Contact Details: Purchase the Biominerales Pharma S A S report to view the information.

Basic Information
Total Employees:
Purchase the Biominerales Pharma S A S report to view the information.
Outstanding Shares:
Purchase the Biominerales Pharma S A S report to view the information.
Incorporation Date:
February 28, 2017
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Purchase this report to view the information.
Fiscal Inspector
Company Performance
Financial values in the chart are available after Biominerales Pharma S A S report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
133.24%
Total operating revenue
133.24%
Operating profit (EBIT)
33.7%
Net Profit (Loss) for the Period
33.7%
Total assets
-32.67%
Total equity
N/A
Operating Profit Margin (ROS)
1635.96%
Net Profit Margin
1635.96%
Return on Equity (ROE)
N/A
Quick Ratio
-0.21%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?